Li Zheng, Xiao Chen, Yang Xiangliang, Li Zifu
Department of Nanomedicine and Biopharmaceuticals, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
National Engineering Research Center for Nanomedicine, Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
Chem Soc Rev. 2025 Jun 3;54(11):5698-5734. doi: 10.1039/d3cs00912b.
Cancer nanomedicines have attracted significant attention in the past several decades, and the physicochemical properties, such as the size, shape, composition, surface charge, hydrophobicity, and mechanical properties, of nanoparticles have been optimized for potent cancer therapy. Since publishing our 2020 tutorial review "Influence of nanomedicine mechanical properties on tumor targeting delivery" in , substantial advancements have been made in understanding the role of mechanical properties in cancer nanomedicine. Notably, transport processes that are dependent on the mechanical properties of nanomedicine, including long circulation, tumor accumulation, and deep penetration, have been extensively studied using various nano-drug delivery systems. These studies have demonstrated that leveraging these mechanical properties can significantly enhance the antitumor efficacy of nanomedicine. In this review, we categorize the advancements in the mechanical properties of cancer nanomedicine into three distinct themes: the interactions between nanoparticles with varied mechanical properties and cells (2002 - present), the impact of these properties on delivery processes (2007 - present), and the strategic use of mechanical properties to boost cancer therapy (2023 - present). We analyze how different mechanical properties of organic, inorganic, hybrid, and biological nanoparticles affect their delivery processes at the macroscopic level, , in tissues, organs and cells. At the microscopic level, their biological and physical interactions with biological barriers, physiological structures, cell membranes, organelles, and other structures reveal the potential mechanism of nanoparticles' mechanical properties in determining their antitumor efficacy. Furthermore, we address the current challenges and future prospects in the mechanical properties of cancer nanomedicine, as well as the clinical translation potential of nanoparticles with diverse mechanical characteristics.
在过去几十年中,癌症纳米药物引起了广泛关注,纳米颗粒的物理化学性质,如尺寸、形状、组成、表面电荷、疏水性和机械性能等,已得到优化以实现有效的癌症治疗。自我们在2020年发表教程综述《纳米药物机械性能对肿瘤靶向递送的影响》以来,在理解机械性能在癌症纳米药物中的作用方面取得了重大进展。值得注意的是,利用各种纳米药物递送系统,对依赖于纳米药物机械性能的转运过程,包括长循环、肿瘤蓄积和深度渗透,进行了广泛研究。这些研究表明,利用这些机械性能可以显著提高纳米药物的抗肿瘤疗效。在本综述中,我们将癌症纳米药物机械性能的进展分为三个不同主题:具有不同机械性能的纳米颗粒与细胞之间的相互作用(2002年至今)、这些性能对递送过程的影响(2007年至今)以及利用机械性能促进癌症治疗的策略(2023年至今)。我们分析了有机、无机、杂化和生物纳米颗粒的不同机械性能如何在宏观层面,即在组织、器官和细胞中,影响它们的递送过程。在微观层面,它们与生物屏障、生理结构、细胞膜、细胞器和其他结构的生物和物理相互作用揭示了纳米颗粒机械性能在决定其抗肿瘤疗效方面的潜在机制。此外,我们还讨论了癌症纳米药物机械性能方面当前面临的挑战和未来前景,以及具有不同机械特性的纳米颗粒的临床转化潜力。